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The serotonergic pathways originating in the dorsal and median raphe nuclei (DR and
MnR, respectively) are critically involved in cortical function. Serotonin (5-HT), acting on
postsynaptic and presynaptic receptors, is involved in cognition, mood, impulse control
and motor functions by (1) modulating the activity of different neuronal types, and (2)
varying the release of other neurotransmitters, such as glutamate, GABA, acetylcholine
and dopamine. Also, 5-HT seems to play an important role in cortical development. Of
all cortical regions, the frontal lobe is the area most enriched in serotonergic axons and
5-HT receptors. 5-HT and selective receptor agonists modulate the excitability of cortical
neurons and their discharge rate through the activation of several receptor subtypes,
of which the 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT3 subtypes play a major role. Little is
known, however, on the role of other excitatory receptors moderately expressed in cortical
areas, such as 5-HT2C, 5-HT4, 5-HT6, and 5-HT7. In vitro and in vivo studies suggest that
5-HT1A and 5-HT2A receptors are key players and exert opposite effects on the activity
of pyramidal neurons in the medial prefrontal cortex (mPFC). The activation of 5-HT1A
receptors in mPFC hyperpolarizes pyramidal neurons whereas that of 5-HT2A receptors
results in neuronal depolarization, reduction of the afterhyperpolarization and increase of
excitatory postsynaptic currents (EPSCs) and of discharge rate. 5-HT can also stimulate
excitatory (5-HT2A and 5-HT3) and inhibitory (5-HT1A) receptors in GABA interneurons to
modulate synaptic GABA inputs onto pyramidal neurons. Likewise, the pharmacological
manipulation of various 5-HT receptors alters oscillatory activity in PFC, suggesting that
5-HT is also involved in the control of cortical network activity. A better understanding
of the actions of 5-HT in PFC may help to develop treatments for mood and cognitive
disorders associated with an abnormal function of the frontal lobe.
Keywords: 5-hydroxytryptamine or serotonin, dorsal raphe nucleus, electrophysiological recordings, GABAergic
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INTRODUCTION
Serotonin (5-hydroxytryptamine, 5-HT) is one of the phylo-
genetically older molecules used in cellular communications.
It is present in the central nervous system (CNS) of verte-
brates and invertebrates and plays the role of neurotransmit-
ter/neuromodulator. It also functions as a developmental signal
in the CNS and regulates a variety of physiological functions in
the periphery (where most 5-HT is present), such as intestinal
motility, platelet aggregation, and vasoconstriction.
Within the CNS, the serotonergic system is involved in a
large number of functions resulting from its widespread inner-
vation of the whole neuraxis. The axons of serotonergic neurons
of the midbrain raphe nuclei reach almost every brain struc-
ture. Action potentials traveling along these axons release 5-HT
which can act on pre- and postsynaptic receptors, coupled to
different signal transduction mechanisms. So far, 14 different
5-HT receptor subtypes have been identified, corresponding to
7 different families: 5-HT1 (5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E,
5-HT1F), 5-HT2 (5-HT2A, 5-HT2B, 5-HT2C), 5-HT3, 5-HT4, 5-
HT5 (5-HT5A, 5-HT5B), 5-HT6, and 5-HT7. With the exception
of the 5-HT3 receptor, a pentameric ligand-gated ion channel
composed of several subunits (up to 5 different ones have been
identified), the rest of 5-HT receptors belong to the superfam-
ily of G-protein coupled receptors and their activation results
mainly in modulatory actions in the neurons expressing these
receptors.
Given the widespread innervation of the brain and the rich-
ness of signals evoked by 5-HT, it is not surprising that the 5-HT
system is the target of many drugs used to treat brain diseases
and also of recreational drugs. For instance, most antidepressant
treatments block the 5-HT transporter and increase the extracel-
lular (or synaptic) 5-HT concentration and hence, they indirectly
elevate the serotonergic tone at pre- and postsynaptic 5-HT recep-
tors. This action is supposed to mediate the therapeutic effect of
these drugs. Moreover, some anxiolytic drugs are 5-HT1A recep-
tor agonists and 5-HT3 receptor antagonists are commonly used
to treat emesis induced by anti-cancer treatments.
On the other hand, drugs of abuse such as cocaine,
amphetamine or MDMA (ecstasy) target monoaminergic trans-
porters, including the 5-HT transporter. Furthermore hallucino-
gens like LSD, DOI, DOB, or DOM are 5-HT2 receptor agonists
whereas atypical antipsychotics act as preferential antagonists of
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these receptors [(Roth et al., 2004); see Geyer and Vollenweider
(2008) for a review].
Among the various 5-HT receptors, the 5-HT1 family has
probably received the largest attention because of the high den-
sity expression in limbic (5-HT1A) and motor (5-HT1B) brain
areas and the various roles subserved by some of its members.
Thus, in addition to being located postsynaptically to 5-HT axons,
5-HT1A and 5-HT1B receptors are autoreceptors in 5-HT neurons
and therefore control the overall (5-HT1A) as well as the local
(5-HT1B) activity of the system. 5-HT1B receptors are also termi-
nal heteroreceptors and modulate the release of various transmit-
ters, including dopamine, glutamate, GABA, and acetylcholine.
Moreover, 5-HT1A receptors are highly expressed by different
neuronal types (mainly pyramidal but also GABAergic) in pre-
frontal cortex (PFC), which suggests an important role in the
control of mood and emotions as well as in cognitive processes.
An extensive review of the characteristics of the serotonergic sys-
tem is beyond the scope of the present review. The reader is
referred to several review papers dealing with the anatomy, phys-
iology, neurochemistry, and neuropharmacology of the 5-HT
system (Jacobs and Azmitia, 1992; Barnes and Sharp, 1999; Adell
et al., 2002; Smythies, 2005; Artigas, 2013). In the following sec-
tions, we focus on the role of 5-HT in the modulation of cortical
activity.
THE CORTICAL 5-HT SYSTEM: RECEPTOR LOCALIZATION
There is growing evidence that the serotonergic pathways orig-
inating in the dorsal and median paphe nuclei (DR and MnR,
respectively) are critically involved in cortical functions. 5-HT
appears to play an important role in the development of the
somatosensory cortex and formation of the barrel cortex. In adult
brain, the axons of 5-HT neurons innervate a large number of
cortical areas, including the entorhinal and cingulate cortices,
which contain a moderate to high density of 5-HT receptors.
However, of all cortical regions, the frontal lobe is the richest area
in serotonergic terminals and 5-HT receptors.
Yet, unlike dopamine, whose function in the PFC has been
extensively studied (Williams and Goldman-Rakic, 1995; Robbins
and Arnsten, 2009), the role of 5-HT in PFC remains less known
than that of dopamine. Indeed, the widespread localization of 5-
HT receptors (particularly of the 5-HT1A, 5-HT2A, and 5-HT2C
subtypes) and the high density of 5 HT axons (greater than in any
other cortical area) in this cortical region suggest an important
role of 5-HT in cognitive and emotional functions depending on
PFC activity. Hence, the selective depletion of 5-HT in the mon-
key frontal cortex impairs cognitive flexibility (increases persever-
ation), and reversal learning (Clarke et al., 2004, 2005), likely via
5-HT2A receptors (Carli et al., 2006; Boulougouris et al., 2007).
In addition, optimized levels of 5-HT in the PFC are important
for behavioral inhibition, as elevated or reduced 5-HT increases
impulsivity (Harrison et al., 1997; Dalley et al., 2002; Winstanley
et al., 2004). In fact, both stimulation of 5-HT1A receptors and
blockade of 5-HT2A receptors decrease impulsivity (Winstanley
et al., 2003; Carli et al., 2006; Talpos et al., 2006), suggesting that
a downregulation of cortical serotonergic activity may effectively
promote behavioral control. 5-HT in the frontal cortex is also
involved in the modulation of attention in humans, an effect that
implicates 5-HT1A, but not 5-HT2A, receptors (Carter et al., 2005;
Scholes et al., 2006). Moreover, as observed for dopamine D1
receptors (Williams and Goldman-Rakic, 1995; Puig and Miller,
2012), the blockade of 5-HT2A receptors in the monkey lateral
PFC avoids the increase in neuronal activity during a working
memory task (Williams et al., 2002), and a study associates allelic
variants of this receptor with memory capacity in humans (De
Quervain et al., 2003). Furthermore, hallucinogens like LSD or
DOI are 5-HT2A receptor agonists, which also suggests a role of
5-HT in the processing of external (sensory) and internal infor-
mation through the activation of 5-HT2A receptors. On the other
hand, 5-HT1A agonists display anxiolytic/antidepressant activ-
ity in animal models (Martin et al., 1990; De Vry, 1995; Carr
and Lucki, 2011) whereas 5-HT1A receptor antagonists reverse
drug-induced cognitive deficits (Harder and Ridley, 2000; Mello
e Souza et al., 2001; Misane and Ögren, 2003). Likewise, preclin-
ical studies suggest that 5-HT4 receptor agonists may exert rapid
antidepressant actions by acting on PFC receptors (Lucas et al.,
2007).
One of the key basic information relevant for the interpreta-
tion of physiological and behavioral data concerning the cortical
5-HT system is the regional and cellular localization of the 5-HT
receptors. Several studies have examined the localization of 5-HT
in the cortex. Early studies using receptor autoradiography and
in situ hybridization enabled to identify the presence of various
5-HT receptors in cortical areas, notably the 5-HT1A, 5-HT2A,
and 5-HT2C subtypes (Pazos and Palacios, 1985; Pazos et al., 1985;
Pompeiano et al., 1992, 1994). Further studies identified the pres-
ence of other receptor subtypes, yet in lower density than these
ones.
5-HT1A receptors are particularly enriched in the rodent
medial PFC (mPFC), entorhinal cortex and, to a lesser extent,
cingulate and retrosplenial cortices. Outside the cortex, they are
densely expressed in the hippocampus, septum and the raphe
nuclei. In the latter location, the receptor is almost exclusively
expressed by 5-HT neurons, where it functions as an autoreceptor
in the plasma membrane of perikarya and dendrites (Riad et al.,
2000). PET scan studies using a radiolabeled selective antagonist
([11C]-WAY-100635) have shown a very similar distribution in
human brain, with an enrichment of the signal in the temporal
and frontal lobes, cingulate cortex and the raphe nuclei (Martinez
et al., 2001). Interestingly, as also observed in rats (Weber and
Andrade, 2010), there is a marked rostro-caudal negative gradi-
ent in the abundance cortical of 5-HT1A receptors, with the largest
abundance in PFC.
Likewise, the neocortex of rodent, primate and human brains
show a large abundance of 5-HT2A receptors, with an enrichment
in frontal regions (Pompeiano et al., 1994; Burnet et al., 1995;
López-Giménez et al., 1998; Hall et al., 2000; Amargós-Bosch
et al., 2004). Lower abundances are found in ventro-caudal part
of CA3, medial mammillary nucleus, striatum (dorsal and ven-
tral) and several brainstem nuclei (Pompeiano et al., 1994; Burnet
et al., 1995; López-Giménez et al., 1998). Interestingly, pyramidal
neurons in the rat PFC that simultaneously project to the ven-
tral tegmental area and the dorsal raphe nucleus express 5-HT2A
receptors (Vázquez-Borsetti et al., 2009, 2011). This reveals a
close anatomical interaction or “loop” between frontal areas and
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dopamine and serotonin neurons of the brainstem, as found in
several electrophysiological studies (Thierry et al., 1979, 1983;
Tong et al., 1996; Hajós et al., 1998; Celada et al., 2001; Martín-
Ruiz et al., 2001). As for 5-HT1A receptors, there is a good
agreement between the autoradiographic and in situ hybridiza-
tion signals, which indicates that the receptor is expressed mainly
in the somatodendritic region. Similar regional distributions have
been reported in human brain using the selective antagonist lig-
and M100907 in vivo (PET scan) or in vitro (autoradiography)
(Hall et al., 2000).
5-HT1A and 5-HT2A receptors are present in a high propor-
tion of cells in some cortical regions. Double in situ hybridization
studies, to label the cellular phenotype and the respective recep-
tor mRNA, have shown that around 50% of pyramidal neurons
(labeled with the vGluT1 mRNA) and 20–30% of GABAergic
interneurons (labeled with GAD65/67 mRNA) express 5-HT1A
and/or 5-HT2A receptor mRNAs in various areas of the PFC
(Santana et al., 2004) (Table 1). Interestingly, about 30% of
parvalbumin-expressing fast-spiking interneurons in the PFC
express 5-HT1A or 5-HT2A receptors which, unlike pyramidal
neurons, are largely distributed in separate neuron populations
(Puig et al., 2010).
Figure 1 shows the localization of the transcripts for 5-HT1A
and 5-HT2A receptors in the PFC of the rat. Interestingly, 5-
HT1A and 5-HT2A receptor transcripts are heavily co-expressed
in rat and mouse PFC. Approximately 80% of the cells expressing
5-HT1A receptor mRNA also express the 5-HT2A receptor mRNA
in all PFC areas examined, except in layer VI and the lower part of
Table 1 | Proportion of pyramidal and local GABAergic neurons that
express the mRNAs encoding 5-HT1A and 5-HT2A receptors.
Pyramidal neurons GABAergic neurons
5-HT1A 5-HT2A 5-HT1A 5-HT2A
mRNA mRNA mRNA mRNA
MOs 54 ± 4 60 ± 2 28 ± 6 28 ± 10
ACAd 54 ± 3 66 ± 5 22 ± 4 32 ± 2
PrL 61 ± 2 51 ± 3 20 ± 1 34 ± 1
ILAa 40 ± 4* 12 ± 1** 22 ± 4 22 ± 3
TT 63 ± 6 81 ± 3*** 24 ± 1 24 ± 2
PIR 60 ± 2 50 ± 3 21 ± 6 24 ± 2
Layer VI 54 ± 3 26 ± 3+ 23 ± 4 11 ± 3++
Data are means of three rats and represent the percentage of the counted
cells expressing the mRNAs of each 5-HT receptor in pyramidal (vGluT1 mRNA-
positive) and GABAergic (GAD mRNA-positive) cells. MOs, secondary motor
area; ACAd, dorsal anterior cingulate area; PrL, prelimbic area; ILA, infralímbic
area; PIR, piriform cortex; TT, tenia tecta. Layer VIa denotes deep areas of the
sensorimotor cortex at prefrontal level.
aThe data of the ILA correspond to its more ventral part, which shows a remark-
able low level of 5-HT2A receptor, whereas cell counts from its dorsal part are
more similar to those of PrL.
*P < 0.05 vs. PrL, TT, and PIR; **P < 0.05 vs. the rest of areas, except layer
VIa (P = 0.9); ***P < 0.05 vs. the rest of areas; +P < 0.05 vs. the rest of areas
except ILA; ++P < 0.05 vs. ACAd and PrL (Tukey test post-ANOVA). Data from
Santana et al. (2004).
the infralimbic area, where the density of cells expressing 5-HT2A
receptors is much lower (Amargós-Bosch et al., 2004; Santana
et al., 2004).
The abundant co-expression of 5-HT1A and 5-HT2A receptors
raises questions about the physiological role of the simultane-
ous occurrence of inhibitory (5-HT1A) and excitatory (5-HT2A)
receptors responding to 5-HT in the same cortical neurons.
Various hypotheses have been examined (Amargós-Bosch et al.,
2004; Puig et al., 2005), but perhaps one of the most convincing
explanations is the putative localization of both receptors in dif-
ferent cellular compartments. Thus, immunohistochemical stud-
ies by several groups—using different antibodies—consistently
show a predominant location of 5-HT2A receptors in the apical
FIGURE 1 | Localization of 5-HT1A and 5-HT2A receptor mRNAs in the
rat PFC using double in situ hybridization histochemistry. (A–C) Coronal
sections of rat PFC showing a large number of cells expressing (A) 5-HT1A
receptors (Dig-labeled oligonucleotides) or (B) 5-HT2A receptors (dark field;
33P-labeled oligonucleotides); (C) an adjacent Nissl-stained section. Note
the abundant presence of cells expressing both receptors in layers II–V, as
well as in piriform cortex (PIR) and tenia tecta (TT). (D–F) Enlargements of
the marked area in panels (A–C). (D,E) Show the presence of a large
number of cells containing 5-HT1A and 5-HT2A receptor transcripts in
cingulate (ACAd) and prelimbic (PL) cortex. Cells in deep layers (VI) express
preferentially 5-HT1A receptor mRNA. (G–J) Individual cells expressing both
receptor transcripts. Occasional cell profiles containing only 5-HT1A (blue
arrowheads) or 5-HT2A receptor mRNAs (red arrowheads) were seen in the
infralimbic cortex (G,I), piriform cortex (H) and taenia tecta (J). Bar size is
1mm in (A–C), 250μm in (D–F), 50μm in (G,H) and 30μm in (I,J).
Reproduced with permission from Amargós-Bosch et al. (2004).
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dendrites (and to a lower extent, cell bodies) of cortical pyra-
midal neurons (Jakab and Goldman-Rakic, 1998, 2000; Jansson
et al., 2001; Martín-Ruiz et al., 2001), where they may amplify
the impact of excitatory synaptic currents. On the other hand,
there is a considerable disagreement in regards to the loca-
tion of cortical 5-HT1A receptors, due to the use of different
antibodies. A homogenous labeling of cell bodies and den-
drites was initially reported (Kia et al., 1996), but more recent
studies performed in rodent, primate, and human brain tis-
sues using a different antibody (Azmitia et al., 1996) show
the exclusive labeling of the axon hillock of pyramidal neu-
rons (De Felipe et al., 2001; Czyrak et al., 2003; Cruz et al.,
2004). This location suggests that 5-HT axons would be able
to establish axo-axonic contacts with pyramidal neurons, simi-
lar to those established by chandelier GABA interneurons, which
would markedly impact on the generation of action poten-
tials. In this way, 5-HT axons reaching apical dendrites would
be able to modulate glutamatergic inputs onto pyramidal cells
(Aghajanian and Marek, 1997; Puig et al., 2003) whereas those
reaching axon hillocks would control the probability of genera-
tion of nerve impulses through the activation of 5-HT1A recep-
tors. However, existing discrepancies on the cellular localization
of 5-HT1A receptors prevent to draw firm conclusions on this
point.
5-HT1B and 5-HT1D receptors show a widespread brain dis-
tribution, with a relative low abundance in cortex. Radioligand
binding and autoradiographic studies have detected the presence
of a high density of 5-HT1B receptors in the basal ganglia and
hippocampal formation, particularly the subiculum (Pazos and
Palacios, 1985; Offord et al., 1988). They are negatively coupled
to adenylate cyclase and activation of 5-HT1B by selective agonists
decreases the forskolin-stimulated adenylate cyclase levels [for
review see Sari (2004)].
The comparison of autoradiographic, in situ hybridization and
immunohistochemcial studies has revealed that 5-HT1B receptors
are located both presynaptically (i.e., on 5-HT axons) and postsy-
naptically to 5-HT neurons, mostly on axons of intrinsic neurons
of the basal ganglia (Riad et al., 2000). Presynaptic 5-HT1B
autoreceptors, however, represent a small proportion of the entire
population of 5-HT1B receptors in the brain because the lesion
of 5-HT neurons does not generally result in a reduction of their
density (Compan et al., 1998). Notwithstanding the low density
of cortical 5-HT1B receptors seen by autoradiography, electro-
physiological studies have identified 5-HT1B receptor-mediated
actions in the cingulate cortex of the rat (Tanaka and North,
1993; see below). The other two members of the 5-HT1 family
(5-HT1E and 5-HT1F receptors) are also present in cortex, partic-
ularly entorhinal cortex, yet their low abundance and the lack of
selective pharmacological tools have hampered the study of their
actions on cortical neurons.
5-HT2B receptors are expressed in a very low density in the
brain. In contrast, 5-HT2C receptors (formerly named 5-HT1C
receptors) are highly expressed in the choroid plexus (where
they were initially identified), various cortical areas in the rodent
brain, particularly the PFC, the limbic system (nucleus accum-
bens, hippocampus, amygdala) and the basal ganglia (caudate
nucleus, substantia nigra). 5-HT2C receptors are also expressed
in the human cortex, yet their abundance relative to other brain
areas appears to be lower than in rat brain (Clemett et al., 2000;
Pandey et al., 2006). Interestingly, immunohistochemical studies
suggest that cortical 5-HT2C receptors are mainly expressed in
pyramidal neurons (Clemett et al., 2000; Puig et al., 2010), and
not in fast-spiking interneurons (Puig et al., 2010), yet data using
a different antibody indicate that more than 50% of the 5-HT2C
receptor immunoreactivity is present in GABAergic neurons (Liu
et al., 2007).
5-HT3 receptors are moderately abundant in the neocortex
and other telecephalic regions, such as the olfactory cortex, the
hippocampus, and the amygdala. Interestingly, most cortical 5-
HT3 receptor mRNA is located in GABAergic interneurons, as
assessed by in situ hybridization (Morales and Bloom, 1997;
Puig et al., 2004). These are calbindin- and calretinin-(but not
parvalbumin-) containing neurons and are located in superficial
cortical layers (I–III) (Morales and Bloom, 1997; Puig et al., 2004)
(Figure 2).
5-HT4 receptors are abundant in the olfactory tubercle,
some structures of the basal ganglia (caudate putamen, ventral
FIGURE 2 | Composite photomicrographs showing the localization of
cells expressing vGluT1 (A), GAD (B), 5-HT3 (C), and 5-HT2A (D) mRNAs
through layers I–VI at the level of the prelimbic area in the rat PFC. The
continuous vertical line denotes the location of the midline whereas the
dotted line shows the approximate border between layer I and II. Pyramidal
neurons (as visualized by vGluT1 mRNA) are present in layers II–VI whereas
GAD mRNA-positive cells are present in all layers, including layer I. Note the
segregation of cells expressing 5-HT3 (C) and 5-HT2A receptors (D). 5-HT3
receptor transcript is expressed by a limited number of cells present in
layers I–III, particularly in the border between layers I and II. However, they
represent 40% of GABAergic neurons in layer I. On the other hand, cells in
these locations, particularly in layer I, do not express 5-HT2A receptors. The
asterisk denotes an artifact of the emulsion, seen in the dark field. Scale
bar = 150μm. Reproduced with permission from Puig et al. (2004).
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striatum), medial habenula, hippocampal formation, and amyg-
dala. The neocortex contains low levels of the 5-HT4 receptor
and its encoding mRNA, as assessed by autoradiography and
in situ hybridization, respectively (Waeber et al., 1994; Vilaró
et al., 1996, 2005). However, studies using single-cell RT-PCR
technique reported that ∼60% of pyramidal neurons recorded in
the PFC contain the 5-HT4 receptor transcript (Feng et al., 2001),
and overexpression of 5-HT4 in the mPFC increases DRN 5-HT
activity (Lucas et al., 2005) likely through descending excitatory
axons reaching the DR (Celada et al., 2001; Vázquez-Borsetti et al.,
2011).
5-HT5 receptors are the less well understood 5-HT recep-
tors. Both 5-HT5A and 5-HT5B receptor subtypes were found in
rodents whereas only the 5-HT5A was identified in human brain.
The 5-HT5A receptor mRNA is found in relative high levels in the
hippocampus, the medial habenula and the raphe but is absent
in cortex. The occurrence of the receptor in the midbrain raphe,
where the cell bodies of 5-HT neurons are located raises the pos-
sibility that it may directly or indirectly influence the activity of
5-HT neurons, and thus the levels of 5-HT in the target struc-
tures. On the other hand, the 5-HT5B receptor mRNA is present
throughout the rat brain, with higher levels in the hippocampus,
hypothalamus, pons, and cortex (Erlander et al., 1993).
The richest brain areas in 5-HT6 receptor mRNA are the
ventral striatum and adjacent areas (nucleus accumbens, olfac-
tory tubercle, islands of Calleja) as well as the dorsal striatum
(caudate-putamen). High levels of 5-HT6 receptor mRNA are also
found in the hypothalamus and the hippocampus, whereas the
cerebral cortex, the substantia nigra, and the spinal cord con-
tain low/moderate levels of the transcript (Gerard et al., 1996).
Immunohistochemical studies have confirmed a similar distribu-
tion of the receptor protein, although the PFC shows a labeling
density greater than that of the mRNA and similar to that of the
hippocampus (Gerard et al., 1997).
Finally, the 5-HT7 receptor mRNA is localized to discrete
regions of the rodent brain. Higher levels are present in the tha-
lamus and the hippocampus whereas moderate levels are seen in
the septum, the hypothalamus, the centromedial amygdala, and
the periaqueductal gray. Autoradiographic studies indicate the
presence of a similar distribution of the binding sites, in the cor-
tex, septum, thalamus, hypothalamus, centromedial amygdala,
periaqueductal gray, and superior colliculus (Gustafson et al.,
1996). A similar distribution of 5-HT7 receptor was reported
in human brain (Martin-Cora and Pazos, 2004). Interestingly,
the 5-HT7 receptor is also localized in the raphe nuclei in both
rodent and human brain, which has raised interest of target-
ing 5-HT receptors as a potential new mechanism to control
brain’s 5-HT levels by regulating the neuronal activity of the
ascending 5-HT systems.
In summary, 5-HT released from axons innervating the cere-
bral cortex can modulate the activity of cortical neurons through
several distinct receptors. However, with few exceptions (see
above) little is known about the cellular phenotype of the neurons
expressing 5-HT receptors, their precise distribution in cortical
layers and the proportion of neurons of each type (e.g., pyra-
midal, stellate, or GABAergic neurons) expressing the receptor
subtypes. The knowledge of these data is deemed important to
identify the cellular elements and local circuitry involved in the
cortical actions of 5-HT.
ROLE OF 5-HT RECEPTORS ON CORTICAL NEURON ACTIVITY
5-HT1A RECEPTORS
The 5-HT1A receptor has been characterized biochemically and
electrophisiologically as being coupled to the Gi/o family of het-
erotrimeric G proteins. Gi/o proteins coupled to 5-HT1A recep-
tors are composed of pertussis toxin sensitive αi/αo subunits. This
coupling mechanism was demonstrated in vivo and in vitro in the
DR (Innis and Aghajanian, 1987). In hippocampal cells (as well
as in 5-HT cells) a similar G protein couples 5-HT1A and GABAB
receptors to potassium channels (Andrade et al., 1986).
5-HT1A receptors are also coupled to potassium and—to
a lesser extent—calcium channels. Intracellular current-clamp
recordings in slices containing the DR had indicated that the
5-HT-mediated inhibition is mediated by an enhancement of
the inward rectifying potassium conductance (Aghajanian and
Lakoski, 1984; Williams et al., 1988). Exogenous application of
5-HT and 5-HT1A agonists also elicit membrane potential hyper-
polarization and decreased the membrane input resistance in DR
5-HT neurons in vitro (Aghajanian and Lakoski, 1984; Sprouse
and Aghajanian, 1987), leading to an overall reduction in the
probability of action potential firing. Similar effects to 5-HT1A
receptor activation have been reported in other neuronal types,
such as hippocampal pyramidal cells (Andrade and Nicoll, 1987).
5-HT1A receptors are also involved in the modulation of exci-
tatory glutamatergic neurotransmission, since their activation
suppresses AMPA-mediated signaling through the inhibition of
CAMKII (Cai et al., 2002a) and reduces NMDA-mediated cur-
rents in PFC neurons (Zhong et al., 2008).
Early in vivo electrophysiological recordings showed that ion-
tophoretic application of 5-HT excited and inhibited differ-
ent cortical neurons (Krnjevic and Phillis, 1963; Roberts and
Straughan, 1967), even though the major effect of 5-HT was
inhibition of firing (Krnjevic and Phillis, 1963; Reader et al.,
1979; Ashby et al., 1994; Zhang et al., 1994). Studies in the
neocortex showed that 5-HT application also induced a hyper-
polarization followed by a depolarization in a subpopulation of
neurons (Davies et al., 1987; Tanaka and North, 1993). These
effects were mediated, respectively by an action of 5-HT on 5-
HT1A and 5-HT2 receptors (Araneda and Andrade, 1991), and
can be likely accounted for by the high co-expression of 5-HT1A
and 5-HT2A receptors in cortical neurons (Amargós-Bosch et al.,
2004). The three major actions of 5-HT on the activity of cortical
neurons (inhibitions, excitations, and biphasic responses) have
been recently found in layer V pyramidal neurons of mice PFC
slices to be mediated by 5-HT1A and 5-HT2A receptors (Avesar
and Gulledge, 2012) (Figure 3). Similarly, both hyperpolarizing
(5-HT1A receptor-mediated) and depolarizing (5-HT2A receptor-
mediated) responses to 5-HT have been demonstrated in human
neocortex in vitro (Newberry et al., 1999).
In entorhinal cortex neurons recorded in the current clamp
mode, 5-HT evoked a biphasic response consisting of a large
amplitude hyperpolarization followed by a slowly developing,
long lasting, and small amplitude depolarization. In voltage
clamp, 5-HT consistently evoked an outward current by a smaller
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FIGURE 3 | Hyperpolarizing and depolarizing effects of 5-HT in layer V
pyramidal neurons of medial prefrontal cortex slices from mice. (A)
Focal (local) application of 5-HT (100μM) elicited a hyperpolarizing response
which was blocked by the 5-HT1A antagonist WAY 100635 (30 nM),
suggesting the expression of 5-HT1A receptors. (B) Focal application
of 5-HT (100μM) elicited a depolarizing response which was blocked by the
5-HT2A antagonist MDL 11939 (500 nM), suggesting the expression of
5-HT2A receptors. (C) Focal application of 5-HT (100μM) elicited a biphasic
response sensitive to the 5-HT2A antagonist MDL 11939 (500 nM). Redrawn
from Avesar and Gulledge (2012) with permission from A. Gulledge.
inward shift of holding current. The outward current was medi-
ated by the activation of 5-HT1A receptors (Ma et al., 2007).
Systemic administration of selective 5-HT1A receptor agonists
suppresses the firing activity of 5-HT neurons in the DR andMnR
(Blier and de Montigny, 1987; Hajós et al., 1995; Casanovas et al.,
2000) and hippocampal neurons (Tada et al., 1999). However,
these agents appear to have a more complex effect on cortical
(PFC) pyramidal neurons, with either a biphasic effect (increase
in firing activity at lower doses followed by decrease at higher
doses) or affecting different neuronal populations in a distinct
manner (most neurons excited by 5-HT1A agonists) (Borsini
et al., 1995; Hajos et al., 1999; Diaz-Mataix et al., 2006; Lladó-
Pelfort et al., 2010, 2012a,b). Thus, the systemic administration
of the selective 5-HT1A receptor agonist 8-OH-DPAT increased
the firing activity of pyramidal neurons and reduced that of fast-
spiking GABAergic interneurons, suggesting a preferential action
of 5-HT1A agonists on 5-HT1A receptors in fast-spiking GABA
interneurons, particularly at lower doses (Lladó-Pelfort et al.,
2012b).
5-HT1B/1D RECEPTORS
Anatomical and pharmacological evidence indicate that 5-HT1B
receptors have an axonal localization in different cerebral path-
ways and it exerts an inhibitory action on neurotransmitter
release (Sari, 2004). Furthermore, electrophysiological evidence
of the role of 5-HT1B receptors in neuronal function is based on
the assessment of inhibitory actions on evoked synaptic potentials
or currents in target neurons whereas neurochemical studies have
examined direct effects on neurotransmitter release.
The control of glutamate release by 5-HT1B receptors has
been described in different brain areas. In slices of cingulate cor-
tex, 5-HT, acting on 5-HT1B receptors, reduced the amplitude
of NMDA and non-NMDA components of synaptic potentials
recorded intracellularly in layer V pyramidal neurons (Tanaka and
North, 1993) (Figure 4). It has been also reported that 5-HT1B
receptors mediate the 5-HT suppression of evoked fast excita-
tory postsynaptic current (evEPSC) in layer V pyramidal neurons
in response to nearby electrical stimulation of cortical afferents
(Lambe and Aghajanian, 2004).
5-HT2A/2C RECEPTORS
5-HT2A receptors are coupled to phospholipases through Gq
proteins. Their activation entrains the production of IP3, dia-
cylglycerol and the mobilization of intracellular Ca2+ stores.
Furthermore, it is widely recognized that it is the main G-protein-
coupled receptor through which 5-HT has excitatory actions.
However, some aspects are highly controversial, including the
localization of receptors responsible for the actions of 5-HT and
5-HT2A agonists.
There is a substantial overlap between the localization of 5-HT
axon terminals and 5-HT2 receptors in rat cortex (Blue et al.,
1988). 5-HT2A receptors are localized both to pyramidal neu-
rons and GABAergic interneurons in the PFC (Willins et al.,
1997; Jakab and Goldman-Rakic, 1998; Santana et al., 2004). 5-
HT2A receptors are highly expressed in large and medium-size
parvalbumin- and calbindin-containing interneurons involved in
the feed-forward inhibition of pyramidal neurons (Jakab and
Goldman-Rakic, 2000; Puig et al., 2010). In the rat frontoparietal
cortex, 5-HT axons are parallel to the apical dendrites of pyrami-
dal neurons expressing 5-HT2A receptors (Jansson et al., 2001).
Additionally, a lower proportion of 5-HT2A receptors was found
presynaptically (Jakab and Goldman-Rakic, 1998; Miner et al.,
2003).
Activation of 5-HT2A receptors exerts complex effects on the
activity of PFC neurons. Thus, the microiontophoretic applica-
tion of DOI suppressed the firing activity of putative pyramidal
neurons in anesthetized rats but enhanced the excitatory effect of
glutamate at low ejection currents (Ashby et al., 1990). In vitro
recordings of identified pyramidal neurons in PFC slices have
revealed that 5-HT2A receptor activation increases spontaneous
EPSCs and depolarizes the recorded cells (Araneda and Andrade,
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FIGURE 4 | The stimulation of 5-HT1B receptors inhibits excitatory
synaptic transmission in rat cingulate cortex. (A) The stimulation
of subcortical white matter elicited excitatory postsynaptic synaptic
potentials (EPSP) dependent on NMDA and non-NMDA currents in in
cingulate cortex pyramidal neurons. The action of 5-HT partially
depressed EPSPs. (B) The reduction of EPSPs by 5-HT was
mimicked by the non-selective 5-HT1B agonist TFMPP and was
antagonized by the 5-HT1B antagonist cyanopindolol. (C) The
depressing action of serotonin appears to be mediated by a
presynaptic action of 5-HT since the depolarizing effect of glutamate
was unaffected by 5-HT application. Reproduced with permission from
Tanaka and North (1993).
1991; Tanaka and North, 1993; Aghajanian and Marek, 1997,
1999a,b; Zhou and Hablitz, 1999; Avesar and Gulledge, 2012)
(Figures 3, 5). In addition, 5-HT can elicit 5-HT2A-mediated
IPSCs through the activation of GABA synaptic inputs (Zhou and
Hablitz, 1999), an effect that can be accounted for by the acti-
vation of 5-HT2A receptors in GABAergic interneurons (Santana
et al., 2004).
Importantly, recent studies have provided new insights into the
role of 5-HT2A-mediated excitations and 5-HT1A-mediated inhi-
bitions in PFC circuits. 5-HT generated 5-HT2A-mediated exci-
tatory or biphasic responses in all callosal/commissural (COM)
neurons responsive to 5-HT in vitro, whereas corticopontine-
projecting neurons (CPn) were universally inhibited by 5-
HT through 5-HT1A receptors (Avesar and Gulledge, 2012).
Additionally, cortico-mesencephalic pyramidal neurons respond
to 5-HT1A and/or 5-HT2A receptor activation, as indicated
by in vivo physiological (Puig et al., 2005) and pharmaco-
logical studies (Celada et al., 2001; Martín-Ruiz et al., 2001;
Bortolozzi et al., 2005). Thus, 5-HT may exert different and
projection-selective actions on PFC pyramidal neurons, activat-
ing cortico-cortical output channels, having mixed actions on
some cortico-subcortical output channels and inhibiting other
cortical pyramidal neurons, particularly CPn neurons. 5-HT2A
receptor-dependent serotonergic excitation of COMneuronsmay
also be related to the parallel rostral-to-caudal gradients found for
cortical 5-HT2A receptors expression (Pazos et al., 1985; Weber
and Andrade, 2010) and COMneuron density (Chao et al., 2009).
One of the most important mechanisms by which 5 HT
increases pyramidal cell excitability seems to be mediated by the
inhibition of the afterhyperpolarizating current (IAHP) typically
observed after a burst of spikes in response to 5-HT2 recep-
tor activation (Araneda and Andrade, 1991; Andrade, 1998).
Accordingly, studies conducted in layer V neurons of PFC have
identified 5-HT2A receptors as the primarily receptor involved in
the inhibitory effect of 5-HT on the slow afterhyperpolarizating
current (IsAHP), suggesting also the contribution of additional
5-HT receptor subtypes (Villalobos et al., 2005). As AHP is
involved in determining neuronal excitability, such an inhibition
could contribute to regulate firing pattern activity of cortical neu-
rons. Interestingly, the 5-HT2A/2C receptor agonist DOImarkedly
affects the firing activity of PFC pyramidal neurons in vivo (Puig
et al., 2003). Systemic DOI administration increased, decreased
or left unaffected the activity of pyramidal neurons in PFC by a
5-HT2A receptor-dependent mechanism. As observed for 5-HT
(Zhou and Hablitz, 1999), inhibitory actions of DOI seems to be
dependent on GABAA receptor tone, suggesting the involvement
of 5-HT2A receptors in GABAergic interneurons.
There seems to be a tight link between 5-HT2A receptors and
glutamatergic transmission. Hence, the excitatory effects of DOI
appear to involve interaction with glutamatergic transmission
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FIGURE 5 | (A) Bath application of 5-HT evoked a depolarization and
induced firing in a pyramidal neuron of the PFC. (B) Effect of ketanserin
(5-HT2A/2C receptor antagonist) on the 5-HT-induced membrane
depolarization. Notice that in the presence of ketanserin 5-HT elicited a
small hyperpolarization. (C,D) Spontaneous IPSCs recorded in a PFC
pyramidal neuron in presence of AP-V and CNQX to block glutamatergic
inputs. (D) IPSCs evoked by the bath application of 5-HT in the same
recording conditions. Note the large increase in the frequency and
amplitude of IPSCs induced by 5-HT. Reproduced with permission from
Araneda and Andrade (1991) (panels A,B) and Zhou and Hablitz (1999)
(panels C,D).
because DOI increases the excitatory effects of glutamate on pre-
frontal neurons (Ashby et al., 1989a, 1990). Likewise, the 5-HT2A
receptor-mediated EPSCs evoked by 5-HT in mPFC slices are
occluded by blockade of AMPA receptors and mGluR II recep-
tor activation (Aghajanian and Marek, 1997, 1999a,b). Moreover,
the modulation of prefrontal NMDA transmission by 5-HT and
DOB appears to involve pre- and postsynaptic 5-HT2A recep-
tors (Arvanov et al., 1999). Likewise, 5-HT modulates NMDA
transmission in PFC via 5-HT1A and 5-HT2A receptors, with
opposite actions of both receptors (Yuen et al., 2008; Zhong et al.,
2008). Finally, the observation that the selective mGluRII ago-
nist LY-379268 reversed the excitatory effect of DOI on pyramidal
neurons in vivo is consistent with these in vitro observations (Puig
et al., 2003).
It has been suggested that in mPFC 5-HT activates 5-HT2A
receptors located putatively on thalamocortical terminals to
release glutamate and evoke EPSCs in pyramidal cells (Aghajanian
and Marek, 1997). This interpretation was based on a number of
observations, including the fact that this effect was antagonized
by AMPA receptor antagonists and mGluR agonists (Aghajanian
and Marek, 1997, 1999a,b). Similarly, the increase in pyramidal
cell firing evoked by systemic DOI administration was depen-
dent on glutamate inputs (Puig et al., 2003). However, the lesion
of the thalamus (including the dorsomedial and centromedial
nuclei which project to mPFC) (Berendse and Groenewegen,
1991; Fuster, 1997) did not abolish the excitatory effects of
DOI on mPFC pyramidal neurons (Puig et al., 2003). Likewise,
in vitro electrophysiological studies in 5-HT2A receptor knockout
mice are also discordant with the existence of presynaptic 5-
HT2A receptors in thalamocortical afferents (Béïque et al., 2007)
and electron microscopy studies have failed to identify 5-HT2A
receptors in excitatory axonal terminals in the mPFC [most are
located postsynaptically (Miner et al., 2003)]. Overall, these data
have raised doubts about the presynaptic mechanisms responsible
for the excitatory actions of 5-HT2A receptors and suggest that
postsynaptic receptors, which make up the majority of cortical
5-HT2A receptors, are involved.
5-HT2A receptors seem to exert a more marked depolarizing
action in early stages of postnatal development, since the depo-
larizing action of 5-HT diminishes with age. Both 5-HT2A and
5-HT7 receptors appears to underlie the depolarizing effect of
5-HT (see below) (Zhang, 2003; Béïque et al., 2004).
There is almost no evidence for a role of 5-HT2C receptors
in the modulation of cortical activity. 5-HT-induced slow excita-
tions in prefrontal interneurons seem to be mediated exclusively
by 5-HT2A receptors, since the 5-HT2C antagonist SB242084
failed to reduce 5-HT excitations previously blocked by a 5-
HT2A/2C antagonist (Puig et al., 2010). This agrees with the
described primary expression of 5-HT2C receptors in pyrami-
dal neurons. Consistently, in the piriform cortex, it was reported
that 5-HT could activate pyramidal neurons via 5-HT2C recep-
tors and GABAergic neurons via 5-HT2A receptors (Sheldon and
Aghajanian, 1991). However, the depolarizing action of 5-HT
in layer V pyramidal neurons of the mPFC does not seem to
depend on 5-HT2C receptor activation since it was not blocked
by the selective antagonist SB 242084 (Béïque et al., 2004). This
inconsistency will require further investigation.
5-HT3 RECEPTORS
5-HT can mediate rapid excitatory responses through the activa-
tion of the 5-HT3A receptor, a ligand-gated ion channel. These
receptors may be involved in cortical actions of 5-HT, since some
5-HT3 receptor antagonists display procognitive effects (Staubli
and Xu, 1995). These agents have been also reported to display
anxiolytic and antipsychotic activity in animal models (Higgins
and Kilpatrick, 1999) and to improve the therapeutic action of
antipsychotic drugs in schizophrenic patients (Sirota et al., 2000).
Likewise, the atypical antipsychotic clozapine is an antagonist of
5-HT3 receptors (Watling et al., 1989; Edwards et al., 1991).
Early microiontophoretic studies showed that 5-HT and 5-
HT3 receptor agonists suppressed pyramidal neuron activity in
rat PFC through the activation of 5-HT3 receptors by a direct
action (Ashby et al., 1989b, 1991, 1992). However, more recent
in vitro studies indicate that 5-HT may also increase pyramidal
neurons IPSCs by activation of 5-HT3 receptors, likely as a result
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of a fast synaptic excitation of local GABAergic neurons (Zhou
and Hablitz, 1999; Férézou et al., 2002; Xiang and Prince, 2003).
The latter observations are consistent with the presence of 5-HT3
receptors in GABAergic interneurons in the rat telencephalon,
including the PFC (Morales and Bloom, 1997; Puig et al., 2004).
In macaque cortex, 5-HT3 receptors are expressed by a subpop-
ulation of calbindin- and calretinin-positive interneurons (Jakab
and Goldman-Rakic, 2000). In vivo studies also show the excita-
tion of GABA interneurons in themPFC through 5-HT3 receptors
(Puig et al., 2004).
OTHER 5-HT RECEPTORS
There is almost no information on the effects of 5-HT or selective
agonists on cortical neurons through the activation of 5-HT4–
5-HT7 receptors. For instance, it has been suggested that 5-HT7
receptor may play a role during early postnatal developing of cor-
tical circuits. In vitro whole cell recordings revealed a shift in
the effect of 5-HT on membrane potential across development
according with coordinated changes in the expression and func-
tion of 5-HT1A, 5-HT2A, and 5-HT7 receptors. Hence, 5-HT in
early postnatal days elicits a marked depolarization of pyramidal
cells (dependent on 5-HT2A and 5-HT7 receptors) which progres-
sively shifts to hyperpolarization (mediated by 5-HT1A receptors).
This change appears to be mainly due to the loss of 5-HT7 recep-
tors together with an increased function of 5-HT1A receptors
(Béïque et al., 2004).
The activation of 5-HT4 receptors has dual effects (enhance-
ment or reduction) on GABA evoked currents in PFC pyramidal
neurons, being the direction of the 5-HT4 receptor-mediated
effect determined by neuronal activity. These observations sug-
gest a flexible mechanism for 5-HT4 receptors to dynamically
regulate synaptic transmission and neuronal excitability in the
PFC network (Cai et al., 2002b; Yan, 2002). Also, extracellu-
lar recordings in rat frontal cortical slices have showed that
bursting activity could be modulated by the application of the
5-HT4 agonist zacopride. Thus, perfusion of zacopride induces
an increase on spontaneous bursting activity (Zahorodna et al.,
2004).
Blockade of 5-HT6 receptors improves cortical performance
in different learning andmemory paradigms, an effect still poorly
understood (Upton et al., 2008). Recent work using whole-cell
path-clamp electrophysiological recordings showed that 5-HT6
agonists reversibly reduced spontaneous glutamatergic transmis-
sion in both striatal and layer V PFC pyramidal neurons, an effect
prevented by preincubation in the selective 5-HT6 antagonists
SB258585. Since no evidence for the expression of 5-HT6 recep-
tors on glutamatergic neurons has been provided and it has been
reported co-localization of this receptor onGAD immunoreactive
neurons (Woolley et al., 2004) these data suggest that modu-
lation of the glutamatergic transmission might be mediated by
5-HT6 receptors expressed by GABAergic neurons (Tassone et al.,
2011).
In vivo ACTIONS OF ENDOGENOUS SEROTONIN ON CORTICAL
NEURONS
Despite the wealth of in vitro studies on the actions of 5-HT
on cortical neurons, the endogenous effects of 5-HT and its
receptors in the regulation of cortical inhibitory and excitatory
responses in vivo is not fully known. The effect of endogenous
5-HT on postsynaptic 5-HT1A receptors has been typically exam-
ined in two forebrain areas, the CA region of the hippocampal
formation and themPFC using extracellular recordings. Electrical
stimulation of the medial forebrain bundle inhibits hippocam-
pal pyramidal neurons, an effect reversed by 5-HT1A receptor
blockade (Chaput and de Montigny, 1988). Similarly, as previ-
ously observed with the microiontophoretic application of 5-HT
(see above), the electrical stimulation of DR/MnR at a physiolog-
ical rate (∼1 spike/s) mainly evoked inhibitory responses in PFC
cells in vivo, which were partly or totally blocked by the selective
5-HT1A antagonist WAY-100635 (Hajós et al., 2003; Amargós-
Bosch et al., 2004; Puig et al., 2005, 2010). DR/MnR stimu-
lation mainly evoked 5-HT1A-mediated inhibitory responses in
two thirds of pyramidal neurons of the mPFC, identified by
antidromic activation from the midbrain. The rest of responses
were orthodromic excitations, either pure (13%) or preceded
by short-latency inhibitions (20%, i.e., biphasic responses) (Puig
et al., 2005) (Figure 6). Excitatory responses were blocked by the
selective 5-HT2A receptor antagonist M100907 (Amargós-Bosch
et al., 2004; Puig et al., 2005).
Intriguingly, the proportion of excitatory responses was
markedly lower than that of inhibitory responses despite the
∼80% co-expression of 5-HT1A and 5-HT2A receptor mRNAs
in PFC neurons (Amargós-Bosch et al., 2004). This observa-
tion agrees with the predominant inhibitory effects of 5-HT on
cortical neurons observed in vitro (see above). The putative dif-
ferential location of 5-HT1A and 5-HT2A receptors in different
compartments of pyramidal neurons may perhaps account for
the greater proportion of inhibitory responses. Should 5-HT1A
receptor be localized on axon hillocks, endogenous 5-HT would
have a profound suppressing effect on action potential genera-
tion. Alternatively, a direct effect of 5-HT1A receptor on ionic
conductances (↑K+ currents) may favor inhibitory vs. excitatory
actions of 5-HTmediated by 5-HT2A receptors, which result from
indirect and long lasting changes of similar ionic conductances
into the opposite direction (↓ K+ currents, ↑ Ca2+ currents).
Interestingly, 5-HT1A and 5-HT2A receptor mRNAs do not co-
localize in parvalbumin-expressing inhibitory neurons of the PFC
(Puig et al., 2010). This supports the notion that 5-HT1A recep-
tors in pyramidal neurons, by down-regulating action potential
output, and 5-HT2A receptors, by enhancing synaptic inputs onto
the dendrites, exert a balanced modulation of cortical pyramidal
networks across layers not available to small local interneurons
(Puig and Gulledge, 2011).
In addition, inhibitory responses elicited in mPFC pyramidal
neurons by raphe stimulation involve a GABAergic component
since they were blocked by WAY-100635 but also by the GABAA
antagonist picrotoxinin (Puig et al., 2005). This GABAergic
response may indeed result from the activation of local GABA
interneurons by axon collaterals of pyramidal neurons projecting
to midbrain. Likewise, 5-HT may also activate PFC GABAergic
neurons through 5-HT2A receptors thus inhibiting pyramidal cell
activity, as observed in vitro (Zhou and Hablitz, 1999). The acti-
vation of 5-HT3 receptors is also likely, given their involvement
in the excitatory responses of a subpopulation of GABAergic
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FIGURE 6 | Representative examples of the responses evoked in
pyramidal neurons of the anterior cingulate and prelimbic areas of the
mPFC by the electrical stimulation of the DR and MnR. (A,B) Short
latency long duration inhibitory responses. (C,D) Pure excitatory responses,
which are often seen in pyramidal neurons with a low firing rate. These
orthodromic excitations have a similar duration after DR or MnR stimulation
but the latency is significantly lower after MnR stimulation, as in the example
seen in the figure. (E,F) Examples of orthodromic excitations response
preceded by short latency inhibitions (biphasic responses). Note the
presence of antidromic spikes in the units recorded (B,C,E,F), resulting from
the presence of a dense connectivity between the PFC and the DR/MnR. The
units in (A) and (D) were antidromically activated at currents higher than
those used to evoke a pyramidal response. Each peristimulus time histogram
consists of 110 triggers (2min). Bin size = 4ms. The arrow in the abcissa
denotes the stimulus artifact (time 0). The arrowheads indicate antidromic
spikes. Reproduced with permission from Puig et al. (2005).
interneurons (Puig et al., 2004; see above). However, a third ele-
ment seems also likely to explain the inhibition given the very
short latency of inhibitory responses (9ms on average) induced
by DR/MnR stimulation. This latency is shorter than the time
required for action potentials to travel along 5-HT axons from
midbrain to PFC (orthodromic potentials; ∼25ms) or pyrami-
dal axons fromPFC tomidbrain (antidromic potentials;∼15ms).
Overall, these observations would be consistent with the existence
of a monosynaptic GABAergic projection from the midbrain
raphe to mPFC, as suggested by anatomical studies (Jankowski
and Sesack, 2002). This pathway would be analogous to the
ascending GABAergic pathway between the ventral tegmental
area and the mPFC or the nucleus accumbens—mesocortical
andmesolimbic pathways, respectively—(Carr and Sesack, 2000),
suggesting a common pattern of control of PFC by monoaminer-
gic nuclei in which monoamine and projection GABA neurons
would be involved.
Similarly to pyramidal neurons, endogenous 5-HT elicits
5-HT1A receptor-mediated inhibitions and 5-HT2A receptor-
mediated excitations in PFC parvalbumin-expressing fast-spiking
interneurons in vivo (Puig et al., 2010). There is also evidence
that 5-HT3 receptors can activate GABA interneurons in the rat
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PFC in vivo. Physiological stimulation of the raphe nuclei excites
local GABAergic neurons located in superficial layers (I–III) of the
prelimbic and cingulate areas. These responses can clearly be dis-
tinguished from 5-HT2A receptor-mediated excitations because
they (a) have shorter onset latency and duration than 5-HT2A
receptor-mediated excitations, (b) show a higher concordance
rate (number of spikes evoked/number of stimulus delivered in
DR/MnR), and (c) are blocked by of the 5-HT3 receptor antag-
onists ondansetron and tropisetron (Puig et al., 2004; Puig and
Gulledge, 2011).
In summary, three possibilities (differential localization and/or
control of ion flows by 5 HT1A and 5-HT2A receptors in pyra-
midal neurons, existence of a raphe-mPFC GABAergic pathway,
and inhibitory action in pyramidal cells mediated by activation
of excitatory 5-HT receptors on GABAergic interneurons), not
mutually exclusive, may account for the predominantly inhibitory
responses elicited by raphe stimulation on pyramidal neurons of
the mPFC. To the best of our knowledge, in vivo responses to
other 5-HT receptors present in low or moderate abundances in
cortex, such as 5-HT2C, 5-HT4, 5-HT6, or 5-HT7 have not been
reported so far.
SEROTONIN MODULATES CORTICAL NETWORK ACTIVITY
Neuronal populations, via their anatomical and functional inter-
connections, can display sophisticated discharge patterns that
arise from the synchronization of their activity. That is, they
can form neural networks whereby synchronous activity can
become oscillatory. Oscillatory activities, ranging from 0.1 up to
few hundred cycles per second, generate small electrical waves
detectable outside the skull through electroencephalographic
(EEG) recordings or intracerebrally through local field potential
(LFP) recordings. Oscillations at several frequency bands have
been recorded in the neocortex during natural sleep, anesthe-
sia, and alertness, where their presence tightly correlates with a
variety of behavioral tasks. During slow-wave sleep (SWS) and
deep anesthesia, slow waves (∼2Hz) and delta waves (1–4Hz)
are prominent (Steriade et al., 1993; Mukovski et al., 2007;
Celada et al., 2008; Puig et al., 2010), which are critical for
memory consolidation and learning (Stickgold, 2005; Marshall
et al., 2006; Landsness et al., 2009). During wakefulness, cor-
tical alpha (10–14Hz) and gamma (30–80Hz) waves correlate
with the modulation of attention, memory, and learning (Fries
et al., 2001; Jensen et al., 2002; Ward, 2003; Buschman and
Miller, 2007; Fries, 2009; Siegel et al., 2009; Benchenane et al.,
2011; Bollimunta et al., 2011; Puig and Miller, 2012), whereas
beta waves (15–30Hz) also play a role in learning (Puig and
Miller, 2012). Work reported over the last decade has suggested
that the synchronization of neural activity in the neocortex and
subcortical structures such as the hippocampus may indeed be
critical for the normal processing of cognitive functions. In fact,
schizophrenia patients, who show clear cognitive impairment
(Elvevåq and Goldberg, 2000; Harvey et al., 2001), display abnor-
mal cortical oscillatory activity in the slow and gamma frequency
bands (Hoffmann et al., 2000; Spencer et al., 2003; Cho et al.,
2006). Likewise, abnormal cortical oscillations can be observed
in a variety of psychiatric disorders (see below). Considering the
growing evidence pointing to an important role of cortical oscil-
lations in cognition and the abundant psychiatric medication
targeting the serotonergic system, the involvement of 5-HT in the
generation and modulation of cortical oscillatory activities is of
high interest, as it will help to identify new targets for psychiatric
treatments.
SEROTONERGIC MODULATION OF CORTICAL OSCILLATIONS
The seminal studies pioneered by Mircea Steriade and colleagues
(Steriade et al., 1993, 1996, 2001; Steriade, 2006) described in
detail the cellular mechanisms underlying the spontaneous slow
rhythms (∼2Hz)—including slow and spindle waves—present
in the neocortex during natural sleep. Slow waves reflect the
spontaneous changes in membrane potential and synchronous
firing of neuronal ensembles coordinated by an underlying slow
oscillation. At a cellular level, they consist of an alternation
between periods of activity (called UP states) and silence (DOWN
states), that are not observed during wakefulness. UP and DOWN
states reflect periods of membrane depolarization and hyperpo-
larization, respectively, within large neuronal networks (Steriade
et al., 1993; Contreras and Steriade, 1995; Mukovski et al., 2007).
Spontaneous low frequency oscillations (∼1Hz) have also been
reported to occur in slices of the ferret visual cortex (Sanchez-
Vives andMcCormick, 2000), suggesting the existence of intrinsic
mechanisms. To our knowledge, the role of 5-HT in the modula-
tion of cortical slow oscillations during natural sleep has not been
addressed, despite the marked activity changes of raphe 5-HT
neurons during sleep and wakefulness.
Mild anesthetics, such as chloral hydrate, can reliably gen-
erate slow oscillations in the neocortex of laboratory animals
that resemble the slow rhythms of natural SWS. This provides
a more convenient preparation to examine how synchronous
activity is modulated by 5-HT and its receptors. Endogenous
5-HT—released after electrical stimulation of the DR in the
midbrain—modulates both the frequency and amplitude of corti-
cal slow-like oscillations recorded in the PFC of anesthetized rats
(Puig et al., 2010). 5-HT release produces a moderate increase in
frequency by promoting rapid initiation of UP states, while reduc-
ing the amplitude and duration of DOWN states (Figure 7). This
indicates that the activity of 5-HT neurons in the DR (and pos-
sibly MnR) may directly regulate the frequency of cortical slow
oscillations by promoting UP states. Thus, despite most pyrami-
dal neurons are inhibited by the physiological release of 5-HT (see
above), 5-HT appears to have an excitatory effect on cortical net-
works in vivo, because UP states are generated by the synchronous
depolarization of large ensembles of cortical neurons. In fact, a
massive release of 5-HT in the cortex following high-frequency
stimulation of the DR completely suppresses cortical slow waves
by promoting a long-lasting depolarization and elimination of
DOWN states (Puig et al., 2010). These excitatory influences of 5-
HT on cortical slow oscillations may be accomplished via 5-HT2A
receptors (Celada et al., 2008; Puig et al., 2010). Hence, pharma-
cological stimulation of 5-HT2A receptors with the hallucinogen
and 5-HT2A receptor agonist DOI and the blockade with the 5-
HT2A/2C antagonist ritanserin desynchronize slow waves in rat
PFC (Figure 8), suggesting that a balanced stimulation of 5-HT2A
receptors is critical for a stable synchronization of cortical slow
waves.
Much less is known about the role of 5-HT in the mod-
ulation of high-frequency oscillations, especially for the alpha
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FIGURE 7 | 5-HT modulates slow waves in the PFC. (A) Stimulation of the
dorsal raphe nucleus (DRN) increases the frequency of cortical slow waves
(<1Hz). Top, Local field potential (LFP) signal showing an epoch of
desynchronization (absence of slow waves) preceding anesthesia-induced
slow-wave sleep (SWS), during which the DRN was stimulated electrically at
1Hz. Boxes 1 and 2 are expanded in (B). Bottom, Change in power of slow
waves over time (red indicates high power, blue low power). White dashed
line marks the frequency of stimulation. Note that the predominant band
(∼0.7 Hz) increases in frequency toward the frequency of stimulation during
DRN stimulation. (B) Top, expanded 10-s traces from (A). Vertical lines
correspond to times of DRN stimulation. Power spectra for 1min segments
that contain the 10-s traces in boxes 1 and 2 are shown on the far right.
Bottom, LFPs were processed off-line for an accurate measure of UP-state
duration. A threshold was set (red line) to discriminate UP states. Note the
increase in UP-state potentials during the stimulations (arrow). Modified from
Puig et al. (2010).
(10–14Hz) and beta (15–30Hz) bands. A correlation between
increases in the power of alpha oscillations in the ventral PFC
and increased levels of 5-HT in whole blood has been found
(Fumoto et al., 2010; Yu et al., 2011). Some more information
has been reported on gamma oscillations. During natural sleep
and anesthesia, gamma oscillations (30–100Hz) are present in
cortex along with slow waves (Steriade, 2006; Puig et al., 2010;
Massi et al., 2012), although their specific involvement in cor-
tical processing is poorly understood. Gamma oscillations are
generated by the synchronous firing of fast-spiking interneuron
networks (Cardin et al., 2009; Sohal et al., 2009), which exert
potent inhibition onto pyramidal neurons and other fast-spiking
neurons.
Interestingly, 5-HT exerts a strong modulation of gamma
oscillations in the PFC of anesthetized rats via 5-HT1A and
5-HT2A receptors (Puig et al., 2010). Specifically, blockade of
5-HT1A receptors increases the amplitude of cortical gamma
waves, the discharge rate of 5-HT1A-expressing fast-spiking
interneurons, and sharpens the synchronization of these neu-
rons to gamma cycles. By contrast, blocking 5-H2A receptors
decreases cortical gamma oscillations and desynchronizes 5-
HT2A-expressing fast-spiking interneurons from gamma waves.
In other words, endogenous 5-HT can dampen or enhance
gamma oscillations by reducing or increasing the activity and
synchronization of 5-HT1A- and 5-HT2A-expressing fast-spiking
interneurons, respectively. Overall, 5-HT’s major effect is a
reduction of cortical gamma oscillations during sleep-like epochs.
Further investigations should establish whether these actions also
occur during wakefulness.
RELEVANCE FOR PSYCHIATRIC DISORDERS
Abnormal oscillatory activities in the cortex have been observed
in a number of neurological and psychiatric disorders (Basar
and Güntekin, 2008). For example, the synchronization of slow
(<1Hz), delta (1–4Hz) and gamma (30–80Hz) oscillations is
reduced in schizophrenia, major depression, and bipolar disor-
der (Keshavan et al., 1998; Hoffmann et al., 2000; Spencer et al.,
2003; Cho et al., 2006; Uhlhaas and Singer, 2006). Impaired
gamma oscillations and synchrony have also been reported in
schizophrenia patients as well, suggesting the existence of net-
work alterations (Spencer et al., 2003; Cho et al., 2006; Uhlhaas
and Singer, 2006; Basar and Güntekin, 2008; Gonzalez-Burgos
and Lewis, 2008; Gonzalez-Burgos et al., 2010).
Interestingly, patients with depression that do not respond to
selective serotonin reuptake inhibitors (SSRIs) have alterations in
alpha power in some cortical areas compared with responders and
healthy control subjects (Bruder et al., 2008), suggesting some
relationship between 5-HT levels and the amplitude of alpha
oscillations.
Animal models of psychiatric disorders are starting to shed
new light into the contribution of 5-HT to normal and abnor-
mal cortical oscillations. Importantly, they are providing valuable
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FIGURE 8 | Distinct modulation of cortical synchrony by 5-HT1A and
5-HT2A/2C receptors. (A) Effects of the 5-HT1A antagonist WAY (green)
and the 5-HT2A/2CR antagonists ritanserin (RIT, red) on the baseline
power (comparison of 30 s epochs before and after drug injection) of
slow, spindle, and gamma oscillations. Note the opposing actions of the
two drugs on the power of gamma oscillations. (B) Examples of the
effects of WAY and RIT on the power of slow waves. Time-frequency
plots and corresponding quantification of the power. WAY did not change
significantly the power of slow-waves but RIT markedly reduced it. Red
depicts high power, blue low power. Representative 10 s traces of the
LFPs are shown on top of the spectrograms. (C) Examples of the
effects of WAY and RIT on the power of gamma waves (same examples
as in B). WAY augmented, whereas RIT reduced, the power of gamma
oscillations. Modified from Puig et al. (2010).
information to better understand the cellular mechanisms by
which psychiatric medication compensates for imbalances in net-
work activity. For instance, the hallucinogen and preferential
5-HT2A receptor agonist DOI disrupts low-frequency oscillations
in the PFC of anesthetized rats (Celada et al., 2008), an effect
reversed by antipsychotic drugs with different pharmacological
targets. While the effect of clozapine can be interpreted by
its competition with DOI at 5-HT2A receptors, the effect of
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haloperidol must necessarily be interpreted at the network level,
given its inability to occupy 5-HT2A receptors at the dose used.
A reduction in slow wave activity has been detected in patients
with schizophrenia during sleep (Hoffmann et al., 2000); hence, a
potential source of this decrease could be an unbalanced stimula-
tion of cortical 5-HT2A receptors.
Interestingly, the disruption of PFC activity evoked by DOI
is similar—yet of smaller magnitude—to that produced by the
NMDA receptor antagonist phencyclidine (PCP) (Kargieman
et al., 2007). Interestingly, PCP effect is also reversed by
haloperidol and clozapine, which suggests a link between the
disrupting action of PCP and DOI on PFC activity and their
psychotomimetic activity. Likewise, the reversal of this effect by
two antipsychotic drugs with different primary targets strongly
suggests a relationship with their therapeutic action. Despite its
low in vitro affinity for 5-HT1A receptors, the reversal by cloza-
pine of PCP effects depends on the in vivo stimulation of such
receptors (Kargieman et al., 2012), as previously observed for the
antipsychotic-evoked release of dopamine in mPFC (Diaz-Mataix
et al., 2005).
FIGURE 9 | Schematic representation of the relationships between the
mPFC and the DR involving 5-HT1A and 5-HT2A receptors. Pyramidal
neurons in the mPFC project densely to the DR/MnR and modulate the
activity of serotonergic neurons via direct and indirect influences (Celada
et al., 2001). In turn, endogenous 5-HT modulates pyramidal cell activity
through the activation of various receptors expressed in the neocortex, of
which 5-HT1A and 5-HT2A receptors play a major role. The latter receptors
are particularly enriched in apical dendrites of pyramidal neurons where
they can facilitate AMPA inputs. A smaller population of 5-HT2A receptors
are expressed by GABA interneurons, including fast-spiking (FS)
interneurons. Pyramidal 5-HT1A receptors may be localized in the axon
hillock, together with GABAA receptors activated by chandelier axons
(Azmitia et al., 1996; De Felipe et al., 2001; Cruz et al., 2004) or in the
somatodendritic compartment (Riad et al., 2000). It is possible that 5-HT
axons reaching the cortex at different levels may exert distinct effects on
pyramidal neurons, depending on a precise topology between certain
5-HT neurons or neuronal clusters within the DR/MnR and 5-HT1A- or
5-HT2A-receptor-rich compartments, in agreement with anatomical studies
showing an association between 5-HT axons and such receptor-rich areas
(De Felipe et al., 2001; Jansson et al., 2001). Also, 5-HT axons reaching
upper layers, including layer I, may activate 5-HT3 receptors located on
GABAergic non-FS interneurons to modulate inputs onto the tufts and
most distant segments of apical dendrites of pyramidal neurons. 5-HT1B
receptors are present on serotonergic axons (not shown) and in axons of
other neuronal types (e.g., glutamatergic) where they regulate
neurotransmitter release and modulate synaptic activity. The scheme
shows also the putative GABAergic projections from DR/MnR to the
mPFC suggested by electrophysiological and anatomical studies (see text).
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Collectively, these studies highlight the importance of 5-HT
in regulating cortical network activity, as well as the complex-
ities of the alterations present in psychiatric disorders and the
compensatory mechanisms mediating the action of psychiatric
medication. Detailed knowledge of the cellular and circuit mecha-
nisms underlying serotonergic modulation of cortical oscillations
in health and disease could provide valuable information for our
understanding of why many schizophrenia and other psychiatric
treatments are largely ineffective at restoring PFC function.
CONCLUSIONS
The assessment of the in vivo and in vitro actions of 5-HT on
cortical neurons and networks has revealed a complex pattern
of action. 5-HT can hyperpolarize pyramidal neurons through
the activation of 5-HT1A receptors, an action that results from
the opening of G protein-coupled inward rectifying K+ chan-
nels. This effect is followed by a reduction of the firing activity
of pyramidal neurons. At the same time, 5-HT can depolarize
the same neurons through 5-HT2A receptors and increase their
excitability. These two receptors appear to be the main players for
the postsynaptic actions of 5-HT in the cerebral cortex. In situ
hybridization studies have revealed the concurrent presence of 5-
HT1A and 5-HT2A receptor mRNAs in a large proportion (∼80%)
of neurons in the PFC. Although several hypotheses have been
put forward, it is yet unclear what determines whether a given
pyramidal neuron responds to 5-HTwith an excitation or an inhi-
bition, although the latter responses predominate, both in vitro
and in vivo. However, the fact that 5-HT induces depolarizing
actions on slow oscillations in vivo suggests that it can exert
excitatory effects on cortical neural networks independent from
action potential generation, a view awaiting further confirma-
tion. The role of these two receptors in the modulation of the
activity of GABAergic interneurons is still poorly understood. A
significant proportion of these neurons, including fast-spiking
interneurons, located in layers II–VI express 5-HT1A and/or 5-
HT2A receptors; yet so far, there are no studies examining the
role of both receptors in the modulation of ion currents. In vivo,
5-H1A receptors decrease, whereas 5-HT2A receptors increase,
spiking rate of fast-spiking interneurons in the PFC (Puig et al.,
2010).
On the contrary, there is a reasonable knowledge on the
role of 5-HT3 receptors in the control of the activity of
GABAergic interneurons. It seems like there is a segregation
of 5-HT1A/5-HT2A receptors on one side, expressed likely in
parvalbumin- and calbindin-containing interneurons and 5-HT3
receptors, expressed in calretinin- and (to a lesser extent)
calbindin-containing neurons. Moreover, interneurons express-
ing 5-HT3 receptors are localized mostly in layers I-III, which
suggests a role in the modulation of inputs reaching the tufts and
upper segments of the apical dendrites of pyramidal neurons.
Another 5-HT receptor for which a role (yet still poorly char-
acterized) has been attributed is the 5-HT1B receptor, whose
activation by 5-HT can presynaptically modulate GABAergic and
glutamatergic inputs onto pyramidal neurons. Figure 9 shows a
schematic representation of the PFC—raphe circuit with themost
important receptors involved in the serotonergic actions in PFC
and their presumed localization.
Unfortunately, there is a poor knowledge of the actions of
5-HT on other receptors, some of which are expressed in signifi-
cant amounts in the neocortex. 5-HT2C receptors can modulate
the activity of pyramidal neurons in piriform cortex, but this
does not seem to be the rule in neocortex. On the other hand,
the neuronal depolarization induced by 5-HT7 receptor activa-
tion disappears few weeks after birth, which suggests a role in
development but not in adulthood. Further studies are indeed
required to clarify the complex role of 5-HT in the modulation
of cortical activity. Current and new knowledge in this area will
help to understand the involvement of 5-HT in cortical functions,
notably those in PFC, a brain region highly enriched of 5-HT ele-
ments and involved in critical brain functions such as cognition
and emotional control, among others.
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